Fumio Nakajima

874 total citations
49 papers, 666 citations indexed

About

Fumio Nakajima is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fumio Nakajima has authored 49 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fumio Nakajima's work include Renal cell carcinoma treatment (5 papers), Glycosylation and Glycoproteins Research (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Fumio Nakajima is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Glycosylation and Glycoproteins Research (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Fumio Nakajima collaborates with scholars based in Japan, United States and Hong Kong. Fumio Nakajima's co-authors include Shin‐Ichiro Nishimura, Kenji Monde, Masamichi Hayakawa, Kengo Harada, Akio Teŕamoto, Kanako Hayashi, Takashi Norisuye, Tadashi Hatano, Akira Tsuji and Yoshihide Ogawa and has published in prestigious journals such as Angewandte Chemie International Edition, Macromolecules and Analytical Biochemistry.

In The Last Decade

Fumio Nakajima

45 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumio Nakajima Japan 17 317 195 88 78 53 49 666
Chris Molenaar Netherlands 18 832 2.6× 102 0.5× 59 0.7× 42 0.5× 56 1.1× 20 1.2k
Christian Jöst Switzerland 18 582 1.8× 156 0.8× 82 0.9× 111 1.4× 163 3.1× 32 1.1k
Rhodri M. L. Morgan United Kingdom 16 616 1.9× 80 0.4× 46 0.5× 48 0.6× 84 1.6× 40 869
Niaobh O’Donoghue Ireland 14 546 1.7× 96 0.5× 99 1.1× 28 0.4× 31 0.6× 22 853
R.G. Ashcroft Australia 13 395 1.2× 72 0.4× 85 1.0× 47 0.6× 60 1.1× 18 686
R. Brückner United States 18 588 1.9× 72 0.4× 76 0.9× 121 1.6× 235 4.4× 59 1.2k
Masanari Kato Japan 19 273 0.9× 170 0.9× 50 0.6× 148 1.9× 45 0.8× 48 929
Valerie Booth Canada 18 552 1.7× 58 0.3× 144 1.6× 22 0.3× 54 1.0× 52 952
Naoki Sakurai Japan 18 540 1.7× 87 0.4× 60 0.7× 94 1.2× 42 0.8× 91 1.1k
Daniel W. Watkins United Kingdom 16 368 1.2× 49 0.3× 65 0.7× 112 1.4× 119 2.2× 34 686

Countries citing papers authored by Fumio Nakajima

Since Specialization
Citations

This map shows the geographic impact of Fumio Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Nakajima more than expected).

Fields of papers citing papers by Fumio Nakajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Nakajima. The network helps show where Fumio Nakajima may publish in the future.

Co-authorship network of co-authors of Fumio Nakajima

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Nakajima. A scholar is included among the top collaborators of Fumio Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Nakajima. Fumio Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanada, Mitsuharu, Fumio Nakajima, Hiroshi Ohmoto, et al.. (2025). Discovery of HM-279, a Potent Inhibitor of ALK5 for Improving Therapeutic Efficacy of Cancer Immunotherapy. Journal of Medicinal Chemistry. 68(7). 7106–7118. 1 indexed citations
2.
Nakajima, Fumio, et al.. (2021). Identification of an allosteric and Smad3-selective inhibitor of p38αMAPK using a substrate-based approach. Bioorganic & Medicinal Chemistry Letters. 43. 128056–128056. 3 indexed citations
3.
Ito, Yujiro, et al.. (2009). [Two cases of urinary retention secondary to benign inflammatory nervous diseases].. PubMed. 55(10). 655–9. 1 indexed citations
4.
Nakajima, Fumio, et al.. (2007). A CASE OF SMALL CELL CARCINOMA IN A DIVERTICULUM OF THE BLADDER. The Japanese Journal of Urology. 98(3). 573–575.
5.
Nakajima, Fumio, et al.. (2004). 2,4-Bis(octadecanoylamino)benzenesulfonic acid sodium salt as a novel scavenger receptor inhibitor with low molecular weight. Bioorganic & Medicinal Chemistry Letters. 14(11). 2791–2795. 8 indexed citations
6.
Yoshida, Masahiro, Fumio Nakajima, Mariko Hara, et al.. (2003). Design, synthesis, and evaluation of β-galactosylceramide mimics promoting β-glucocerebrosidase activity in keratinocytes. Bioorganic & Medicinal Chemistry Letters. 13(5). 813–815. 18 indexed citations
7.
Shinojima, Toshiaki, Fumio Nakajima, & Jun Koizumi. (2002). Efficacy of 3‐D computed tomographic reconstruction in evaluating anatomical relationships of colovesical fistula. International Journal of Urology. 9(4). 230–232. 15 indexed citations
8.
Nakajima, Fumio, et al.. (2000). NMR Analysis of tautomerisms of active pinacidil-Type potassium channel openers and a less active one. Bioorganic & Medicinal Chemistry Letters. 10(21). 2463–2466. 3 indexed citations
9.
Hayakawa, Masamichi, Fumio Nakajima, Akira Tsuji, et al.. (1998). CYTOKINE LEVELS IN CYSTIC RENAL MASSES ASSOCIATED WITH RENAL CELL CARCINOMA. The Journal of Urology. 159(5). 1459–1464. 11 indexed citations
10.
Kuruma, Hidetoshi, et al.. (1998). [Intraperitoneal dissemination of testicular tumor: a case report].. PubMed. 44(6). 423–5. 2 indexed citations
11.
Hayakawa, Masamichi, et al.. (1998). Simultaneous Presentation of Malignant Lymphoma of the Kidney and Multiple Myeloma of the Bone Marrow. International Journal of Urology. 5(4). 374–376. 4 indexed citations
12.
Asano, Tomohiko, et al.. (1997). URINARY NEOPTERIN LEVELS IN PATIENTS WITH GENITOURINARY TRACT MALIGNANCIES. The Japanese Journal of Urology. 88(1). 53–58. 2 indexed citations
13.
Hayakawa, Masamichi, Tadashi Hatano, Akira Tsuji, Fumio Nakajima, & Yoshihide Ogawa. (1996). Patients with renal cysts associated with renal cell carcinoma and the clinical implications of cyst puncture: a study of 223 cases. Urology. 47(5). 643–646. 45 indexed citations
14.
Nakajima, Fumio, Fumihiro Kimura, Tomohiko Asano, et al.. (1996). Complications of femoral vein catheterization as hemodialysis access.. Nihon Toseki Igakkai Zasshi. 29(11). 1485–1489.
15.
Hayakawa, Masamichi, et al.. (1995). STUDY ON CLINICAL COURSES OF 7 PATIENTS UNDERGONE RESECTION OF ADJACENT ORGANS FOR TREATMENT OF LOCALLY EXTENSIVE RENAL CELL CARCINOMA. The Japanese Journal of Urology. 86(7). 1302–1305. 1 indexed citations
16.
Kimura, Fumihiro, et al.. (1995). EXPRESSION OF GP160 mRNA IN RENAL CELL CARCINOMA: AN ATTEMPT TO PREDICT THE SENSITIVITY OF IFN-^|^alpha; THERAPY. The Japanese Journal of Urology. 86(9). 1424–1428. 1 indexed citations
17.
Watanabe, Shinichiro, Fumihiro Kimura, Atsushi Kyan, et al.. (1995). CLINICAL STUDY ON FOURNIER'S GANGRENE. The Japanese Journal of Urology. 86(6). 1137–1141. 2 indexed citations
18.
Murata, Y., et al.. (1995). Non-selective Effects of Amiloride and Its Analogues on Ion Transport Systems and Their Cytotoxicities in Cardiac Myocytes. The Japanese Journal of Pharmacology. 68(3). 279–286. 31 indexed citations
19.
Taoka, Tadami, et al.. (1977). An Improved Ultra-High Temperature Microscope and Its Functional Features. Journal of the Japan Institute of Metals and Materials. 41(3). 250–255.
20.
Kikuchi, Kokichi, et al.. (1965). AN AUTOPSY CASE OF PRIMARY OSTEOGENIC SARCOMA OF THE URINARY BLADDER. Acta Pathologica Japonica. 15(3). 287–293. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Molenaar Breakdown of academic impact, for papers by Christian Jöst Breakdown of academic impact, for papers by Rhodri M. L. Morgan Breakdown of academic impact, for papers by Niaobh O’Donoghue Breakdown of academic impact, for papers by R.G. Ashcroft Breakdown of academic impact, for papers by R. Brückner Breakdown of academic impact, for papers by Masanari Kato Breakdown of academic impact, for papers by Valerie Booth Breakdown of academic impact, for papers by Naoki Sakurai Breakdown of academic impact, for papers by Daniel W. Watkins
Rankless by CCL
2026